"
Team:Imperial College London/M1/PKU
From 2009.igem.org
JamesField (Talk | contribs) (→Phenylalanine Hydroxylase Model) |
(→Useful Links) |
||
| (13 intermediate revisions not shown) | |||
| Line 2: | Line 2: | ||
===Phenylketonuria=== | ===Phenylketonuria=== | ||
| - | [[Image:II09_PAH_Action.png|right| | + | [[Image:II09_PAH_Action.png|right|250px]] |
| - | + | Phenylketonuria (PKU) is an autosomal recessive genetic disorder where the body is unable to break down the amino acid phenylalanine. This is because of a deficiency of an enzyme called phenylalanine hydroxylase (PAH), which converts phenylalanine to tyrosine. Absence of PAH causes phenylalanine to break down into phenylketone instead. A chronically high level of phenylalanine, called hyperphenylalaninemia will result. Phenylalanine then accumulates in blood and tissues and results in characteristic symptoms of PKU. Left untreated, PKU can lead to problems with brain development resulting in progressive mental retardation and brain damage.<br><br><br> | |
| - | Phenylketonuria (PKU) is an autosomal recessive genetic disorder where the body is unable to break down the amino acid phenylalanine. This is because of a deficiency of an enzyme called phenylalanine hydroxylase (PAH), which converts phenylalanine to tyrosine. Absence of PAH causes phenylalanine to break down into phenylketone instead. A chronically high level of phenylalanine, called hyperphenylalaninemia will result. Phenylalanine then accumulates in blood and tissues and results in characteristic symptoms of PKU. Left untreated, PKU can lead to problems with brain development resulting in progressive mental retardation and brain damage.<br><br> | + | <html><left> |
| - | Current treatments | + | <img style="border:0px solid #000;" src="http://upload.wikimedia.org/wikipedia/commons/1/16/Phenylketonuria_testing.jpg" width="250"> |
| + | </left></html> | ||
| + | PKU is usually detected at birth, and all new born babies are tested for the disease using a heel prick test. However, there is currently no cure for the condition. Current treatments are centred around following a very strict low-protein diet. By engineering the <i>E.ncapsulator</i> to manufacture PAH, we hope that our cells can be taken as a dietary supplement to replace the missing PAH. This will break down phenylalanine from the diet in the gut, before it is absorbed into the bloodstream. | ||
=== Useful Links === | === Useful Links === | ||
[http://www.nspku.org/ NSPKU: National Society for Phenylketonuria] | [http://www.nspku.org/ NSPKU: National Society for Phenylketonuria] | ||
| + | <br><br> | ||
| + | <html><center><a href="https://2009.igem.org/Team:Imperial_College_London/M1/EnzymeDelivery#Phenylalanine_Hydroxylase_(PAH)"><img width=150px src="https://static.igem.org/mediawiki/2009/8/8e/II09_Back2Enz.png"></a></center> | ||
| + | </html> | ||
| + | |||
| + | |||
{{Imperial/09/TemplateBottom}} | {{Imperial/09/TemplateBottom}} | ||
Latest revision as of 18:33, 12 October 2009
Phenylketonuria
Phenylketonuria (PKU) is an autosomal recessive genetic disorder where the body is unable to break down the amino acid phenylalanine. This is because of a deficiency of an enzyme called phenylalanine hydroxylase (PAH), which converts phenylalanine to tyrosine. Absence of PAH causes phenylalanine to break down into phenylketone instead. A chronically high level of phenylalanine, called hyperphenylalaninemia will result. Phenylalanine then accumulates in blood and tissues and results in characteristic symptoms of PKU. Left untreated, PKU can lead to problems with brain development resulting in progressive mental retardation and brain damage.
Useful Links
[http://www.nspku.org/ NSPKU: National Society for Phenylketonuria]
